Literature DB >> 26079417

The effect of white matter hyperintensities on neurodegeneration in mild cognitive impairment.

Giuseppe Tosto1, Molly E Zimmerman2, Jamie L Hamilton3, Owen T Carmichael4, Adam M Brickman5.   

Abstract

INTRODUCTION: It is unclear whether white matter hyperintensities (WMHs), magnetic resonance imaging markers of small-vessel cerebrovascular disease, promote neurodegeneration and associated clinical decline in Alzheimer's disease (AD), or simply co-occur with recognized pathogenic processes.
METHODS: In 169 patients with mild cognitive impairment, followed for 3 years, we examined the association of (1) baseline regional WMH and cerebral spinal fluid-derived t-tau (total tau) with entorhinal cortex atrophy rates, as a marker of AD-related neurodegeneration, and conversion to AD; and (2) baseline regional WMH with change in t-tau level.
RESULTS: In participants with low baseline t-tau, higher regional WMH volumes were associated with faster entorhinal cortex atrophy. Higher parietal WMH volume predicted conversion to AD in those with high t-tau. Higher parietal and occipital WMH volumes predicted increasing t-tau. DISCUSSION: WMHs affect AD clinical and pathologic processes both directly and interacting with tau.
Copyright © 2015 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; CSF tau; Mild cognitive impairment; White matter hyperintensities

Mesh:

Substances:

Year:  2015        PMID: 26079417      PMCID: PMC4677059          DOI: 10.1016/j.jalz.2015.05.014

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  45 in total

1.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease.

Authors:  K Chalmers; G Wilcock; S Love
Journal:  Neuropathol Appl Neurobiol       Date:  2005-12       Impact factor: 8.090

2.  Comparison of gray matter and metabolic reduction in mild Alzheimer's disease using FDG-PET and voxel-based morphometric MR studies.

Authors:  Kazunari Ishii; Hiroki Sasaki; Atsushi K Kono; Naokazu Miyamoto; Tetsuya Fukuda; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-31       Impact factor: 9.236

Review 3.  Cerebrovascular disease in African Americans.

Authors:  P B Gorelick
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

4.  Vascular burden and Alzheimer disease pathologic progression.

Authors:  Raymond Y Lo; William J Jagust
Journal:  Neurology       Date:  2012-09-12       Impact factor: 9.910

5.  The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.

Authors:  M F Elias; A Beiser; P A Wolf; R Au; R F White; R B D'Agostino
Journal:  Arch Neurol       Date:  2000-06

6.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

7.  Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) study.

Authors:  Edo Richard; Alida A Gouw; Philip Scheltens; Willem A van Gool
Journal:  Stroke       Date:  2010-01-07       Impact factor: 7.914

8.  Dissociable effects of Alzheimer disease and white matter hyperintensities on brain metabolism.

Authors:  Thaddeus J Haight; Susan M Landau; Owen Carmichael; Christopher Schwarz; Charles DeCarli; William J Jagust
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

9.  Standardization of analysis sets for reporting results from ADNI MRI data.

Authors:  Bradley T Wyman; Danielle J Harvey; Karen Crawford; Matt A Bernstein; Owen Carmichael; Patricia E Cole; Paul K Crane; Charles DeCarli; Nick C Fox; Jeffrey L Gunter; Derek Hill; Ronald J Killiany; Chahin Pachai; Adam J Schwarz; Norbert Schuff; Matthew L Senjem; Joyce Suhy; Paul M Thompson; Michael Weiner; Clifford R Jack
Journal:  Alzheimers Dement       Date:  2012-10-27       Impact factor: 21.566

10.  Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community.

Authors:  Adam M Brickman; Frank A Provenzano; Jordan Muraskin; Jennifer J Manly; Sonja Blum; Zoltan Apa; Yaakov Stern; Truman R Brown; José A Luchsinger; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-12
View more
  42 in total

1.  Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Authors:  Santiago Rojas; Anna Brugulat-Serrat; Nuria Bargalló; Carolina Minguillón; Alan Tucholka; Carles Falcon; Andreia Carvalho; Sebastian Morán; Manel Esteller; Nina Gramunt; Karine Fauria; Jordi Camí; José L Molinuevo; Juan D Gispert
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

2.  A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.

Authors:  Michael L Alosco; Michael A Sugarman; Lilah M Besser; Yorghos Tripodis; Brett Martin; Joseph N Palmisano; Neil W Kowall; Rhoda Au; Jesse Mez; Charles DeCarli; Thor D Stein; Ann C McKee; Ronald J Killiany; Robert A Stern
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 3.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

4.  White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network.

Authors:  Seonjoo Lee; Fawad Viqar; Molly E Zimmerman; Atul Narkhede; Giuseppe Tosto; Tammie L S Benzinger; Daniel S Marcus; Anne M Fagan; Alison Goate; Nick C Fox; Nigel J Cairns; David M Holtzman; Virginia Buckles; Bernardino Ghetti; Eric McDade; Ralph N Martins; Andrew J Saykin; Colin L Masters; John M Ringman; Natalie S Ryan; Stefan Förster; Christoph Laske; Peter R Schofield; Reisa A Sperling; Stephen Salloway; Stephen Correia; Clifford Jack; Michael Weiner; Randall J Bateman; John C Morris; Richard Mayeux; Adam M Brickman
Journal:  Ann Neurol       Date:  2016-04-27       Impact factor: 10.422

Review 5.  DNA damage in the oligodendrocyte lineage and its role in brain aging.

Authors:  Kai-Hei Tse; Karl Herrup
Journal:  Mech Ageing Dev       Date:  2016-05-26       Impact factor: 5.432

6.  Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Authors:  Patrick J Lao; José Gutierrez; David Keator; Batool Rizvi; Arit Banerjee; Kay C Igwe; Krystal K Laing; Mithra Sathishkumar; Fahmida Moni; Howard Andrews; Sharon Krinsky-McHale; Elizabeth Head; Joseph H Lee; Florence Lai; Michael A Yassa; H Diana Rosas; Wayne Silverman; Ira T Lott; Nicole Schupf; Adam M Brickman
Journal:  Ann Neurol       Date:  2020-10-09       Impact factor: 10.422

7.  The effect of white matter hyperintensities on cognition is mediated by cortical atrophy.

Authors:  Batool Rizvi; Atul Narkhede; Briana S Last; Mariana Budge; Giuseppe Tosto; Jennifer J Manly; Nicole Schupf; Richard Mayeux; Adam M Brickman
Journal:  Neurobiol Aging       Date:  2017-12-16       Impact factor: 4.673

8.  Cerebrospinal fluid β-amyloid42 and neurofilament light relate to white matter hyperintensities.

Authors:  Katie E Osborn; Dandan Liu; Lauren R Samuels; Elizabeth E Moore; Francis E Cambronero; Lealani Mae Y Acosta; Susan P Bell; Michelle A Babicz; Elizabeth A Gordon; Kimberly R Pechman; L Taylor Davis; Katherine A Gifford; Timothy J Hohman; Kaj Blennow; Henrik Zetterberg; Angela L Jefferson
Journal:  Neurobiol Aging       Date:  2018-04-03       Impact factor: 4.673

Review 9.  Getting to the Heart of Alzheimer Disease.

Authors:  Joshua M Tublin; Jeremy M Adelstein; Federica Del Monte; Colin K Combs; Loren E Wold
Journal:  Circ Res       Date:  2019-01-04       Impact factor: 17.367

10.  An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Lidia Sarro; Nirubol Tosakulwong; Christopher G Schwarz; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Samantha M Zuk; Robert I Reid; Mekala R Raman; Bradley F Boeve; Tanis J Ferman; David S Knopman; Giancarlo Comi; Massimo Filippi; Melissa E Murray; Joseph E Parisi; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Kejal Kantarci
Journal:  Alzheimers Dement       Date:  2016-08-10       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.